Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Clinico-radiologic profile of spinal cord multiple sclerosis in adults.
Intractable nausea and vomiting as presenting manifestation of neuromyelitis optica.
Prospective study on retinal nerve fibre layer thickness changes in isolated unilateral retrobulbar optic neuritis.
Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
Oligodendroglial Development: New Roles for Chromatin Accessibility.
A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating fingolimod in patients with relapsing-remitting multiple sclerosis.
Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
Acute disseminated encephalomyelitis and other inflammatory demyelinating variants.
Clinical outcome measures in multiple sclerosis.
Clinical Neurophysiology in multiple sclerosis - From diagnostic tool to biomarker.
IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient.
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.
Cannabinoids and autoimmune diseases: A systematic review.
Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.
Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage.
Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy.
The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom.
Glucocorticoid-induced apoptosis in animal models of multiple sclerosis.
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives.
BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity.
Pages
« first
‹ previous
…
653
654
655
656
657
658
659
660
661
…
next ›
last »